Hulagno, John Kyle A.

HRN: 17-30-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
06/13/2022
06/20/2022
IV
1.5
Q8
Indirect Inguinal Hernia
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: